Do biologics help taper steroids in Adult Still’s Disease?
Adult Still’s Disease is labeled as a rare disease as the prevalence of the…
View Resource
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants
A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved…
View Resource
Cutoffs for Systemic Juvenile Arthritis Disease Activity Score
An international cohort of children with systemic Juvenile idiopathic arthritis (Still’s disease) validated the…
View Resource
The Cartel is Coming for Rheumatology
“What Do Blockbuster Drugs & The Black Market All Have in Common?” asked Dr.…
View Resource
Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 Alleles
Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…
View Resource
Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 Patients
JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…
View Resource
AOSD: complicated disease or a disease with complications?
Adult onset Still’s disease (AOSD) is a little bit of both: it can be…
View Resource
ACR Best Abstracts – Day 3
The last day was jammed with important reports and research including the late breaking…
View Resource
New Biomarkers and Therapeutics Show Potential in Still's Disease
Adult-onset Still’s disease (AOSD) is a rare complex, sporadic, systemic autoinflammatory disease similar to…
View Resource
No Great Options for Treating VEXAS
For patients with the auto-inflammatory disease VEXAS, treatment decisions are unfortunately fraught with tradeoffs…
View Resource